Zimmer Knee is Growing – But is it Growing Fast Enough?

Guidepoint Qsight captured insights into the overall U.S. Orthopedics Knee market, identifying tremendous double-digit growth in Q2 2021, up 13.5% from Q1 2021.

Although Zimmer Biomet reported sequential growth (+11.6%) for the U.S. Orthopedic Knee market, Qsight data indicates a loss of share in Q2 2021, marking the second consecutive quarter that Zimmer Knee has lost ground to its’ competitors.

Looking ahead to Q3 2021, we surveyed a panel of physicians to gather their outlook on market growth and manufacturer share expectations. Despite expecting a 5.3% growth in the U.S. Orthopedic Knee market, all signs point to Zimmer losing unit-share once again.

Despite uncertainty in elective procedure volumes as COVID-19 Delta variant cases surge, all eyes will be on Zimmer Knee performance in the second half of 2021.

For more insights into expected growth rates and unit-share shifts among key MedTech markets and manufacturers, view our recent TRACKER Alerts here.

Post created by: Sean Sookhoo, Vice President of Market Research, Ariana Tsanas, Research Operations Analyst, Skylar Gross, Healthcare Analyst, and Shimul Sheth, Senior Quantitative Analyst

Leave a comment

Privacy Preferences
When you visit our website, it may store information through your browser from specific services, usually in form of cookies. Here you can change your privacy preferences. Please note that blocking some types of cookies may impact your experience on our website and the services we offer.